Clinical study to evaluate the safety and effectiveness of autologous COVID-19 antigen-specific T cell therapy in patients infected with SARS-Coronavirus-2 for a long period of timeeness of antigen specific T cell therapy

An investigator's initiated trial to evaluate the safety of cytokine-induced killers during early transplant period of autologous hematopoeitic stem cell transplant recipients

Pilot study of bone marrow-derived mesenchymal stem cells for the treatment of refractory hemorrhagic cystitis occurring after hematopoietic stem cell transplantation

A phase I study to evaluate the safety of four repeated infusions of bone marrow-derived mesenchymal stem cells for the treatment of steroid-refractory and progressive chronic graft-versus host disease

The safety and efficacy of EBV specific cytotoxic T cell in patients with EBV positive post-transplant lymphoproliferative disease

Safety and efficacy of administration of EBV specific cytotoxic T lymphocytes in chemotherapy responding EBV positive NK/T cell lymphoma patients.